Article PDF
Avoid common mistakes on your manuscript.
References
Campbell, M-, Adams, P., Small, A. M., Tesch, L. M., & Currens, E. L. (1988). Naltrexone in infantile autism.Psychopharmacology Bulletin, 24, 135–139.
Campbell, M., Anderson, L. T., Small, A. M., Locasio, J., Lynch, N. S., & Choroco, M. C. (1990). Naltrexone in autistic children: a double-blind and placebo controlled study.Psychopharmacology Bulletin, 26.
Campbell, M. C., Overall, J. E., Small, A. M., Sokol, M. S., Spencer, E. K., Adams, P., Foltz, R. L., Monti, K. M., Perry, R., Nobler, M., & Roberts, E. (1989). Naltrexone in autistic children: An acute open dose range tolerance trial.Journal of Clinical Psychophnrmacology, 9, 448–449.
Davidson, S., Til-Ad, I., Rogovin, H., Laron, Z., & Reisner, S. H. (1987). Cardiorespiratory depression and plasma b-endorphin levels in low-birth-weight infants during the first day of life.American Journal of Diseases of Children, 141, 145–148.
Gilberg, C., Terenius, L., & Lonnerholm, G. (1985). Endorphin activity in childhood psychosis.Archives of General Psychiatry, 42, 780.
Herman, B. H., Hammock, M. K., Arthur-Smith, A., Egan, J., Chatoor, L., Werner, A., & Zelnik, N. (1987). Naltrexone decreases self-injurious behavior.Annals of Neurology, 22, 550–552.
Hoshino, Y., Yokoyama, F., Watanabe, M., Murata, S., Kaneko, M., & Kumashiro, H. (1987). The diurnal variation and response to dexamethasone suppression test of saliva cortisol level in autistic children.Japanese Journal of Psychiatry and Neurology, 41, 227–235.
Jensen, J. B., Realmuto, G. M., & Garfinkel, B. D., (1985). The dexamethasone suppression test in infantile autism.Journal of the American Academy of Child Psychiatry, 24, 263–265.
Panksepp, J. (1979). A neurochemical theory of autism.Trends in Neurosciences, 2, 174–177.
Panksepp, J., Conner, R., Forister, P. K., Bishop, P., & Scott, J. P. (1983). Opioid effects on social behavior of kennel dogs.Applied Animal Etiology, 10, 63–74.
Richardson, J. S., & Zaleski, W. A. (1983). Naloxone and self-mutilation.Biological Psychiatry, 18, 99–101.
Sahley, T. L., & Panksepp, J. (1987). Brain opioids and autism: An updated analysis of possible linkages.Journal of Autism and Developmental Disorders, 17, 201–216.
Sandman, C. A., Barron, J. L., & Colman, H. (1990a). An orally administered opiate blocker, naltrexone, attenuates self-injurious behavior.American Journal of Mental Retardation, 95, 93–102.
Sandman, C. A., Barron, J. L., Chicz-DeMet, A., & DeMet, E. (1990b). Plasma b-endorphin and cortisol levels in autistic patients.American Journal of Mental Retardation, 95, 84–92.
Sandman, C. A., Datta, P., Barron, J. L., Hoehler, F., Williams, C., & Swanson, J. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients.Applied Research in Mental Retardation, 4, 5–11.
Sandman, C. A., & Yessaian, N. (1986). Persisting subsensitivity of the striatal dopamine system after fetal exposure to b-endorphin.Life Sciences, 39, 1755–1763.
Weizman, R., Weizman, A., Tyano, S., Szekely, B. A., & Sarne, Y. H. (1984). Humoral-endorphin blood levels in autistic, schizophrenic and healthy subjects.Psychopharmacology, 82, 368–370.
Zadina, J. E., Kastin, A. J., Manasco, P. K., Pignatiello, M. F., & Nastiuk, K. L. (1987). Long-term hyperalgesia induced by neonatal b-endorphin and morphiceptin is blocked by neonatal Tyr-MIF-1.Brain Research, 409, 10–18.
Author information
Authors and Affiliations
Additional information
The support of Francis M. Crinella, Director, SDRI, is appreciated. The assistance of Lou Sarrao, Hugh Köhler, Carol Bitcon, Nadia Atie, Pal Donnelly, and the staff of Program V is sincerely appreciated. Supported in part by grant MH41446 NIMH.
Rights and permissions
About this article
Cite this article
Sandman, C.A., Barron, J.L., Chicz-DeMet, A. et al. Brief report: Plasma Β-endorphin and cortisol levels in autistic patients. J Autism Dev Disord 21, 83–87 (1991). https://doi.org/10.1007/BF02207000
Issue Date:
DOI: https://doi.org/10.1007/BF02207000